Color Health
Virtual cancer clinic with genetic testing and oncologist-led care, sold through employers and health plans.
Color's licensure and oncology staffing keep AI tools and fast followers out of its exact lane, but a stale valuation and untested payer economics leave the business case open.
Color Health is a company that helps cancer patients by connecting them with oncologists and genetic testing through its own medical offices and labs across all 50 states. It is hard for a startup to quickly replace because it holds real licenses, certifications, and prescribing authority that take years to build, plus it has relationships with employers who pay for its services. However, other companies like Thyme Care and Included Health are already offering similar guidance to cancer patients through employer health plans, and giant health insurers like UnitedHealth and CVS own their own networks with the same licenses and distribution power. The picture could flip if Color raises new funding at a realistic valuation, or if its deal with Priority Health starting in early 2027 proves the employer channel actually makes money.
Thyme Care or AccessHope earns ASCO Certification. Erases Color's stated May 2026 quality-certification differentiator.
Priority Health Jan 2027 go-live utilization and enrollment numbers are disclosed. Tests whether payer distribution actually converts into paying, engaged members.
- $4.6B valuation, last priced Nov 2021
- ~$219.5M estimated revenue, unaudited
- 591 employees, down 22.5% from 2023 peak
- No priced funding round since November 2021 despite $4.6B valuation, raising down-round risk.
- Integrated payers Optum and CVS/Aetna could insource virtual oncology and pull contracts.
- Priority Health go-live in January 2027 utilization and conversion outcomes unproven.
- Revenue figures remain undisclosed and unaudited, obscuring true financial health.
- Federal litigation over NIH funding could disrupt partner programs like All of Us.
| Rival | Direction | Evidence |
|---|---|---|
| GRAIL | contesting | NHS-Galleri trial reportedly missed primary endpoint for reducing late-stage diagnoses, mid-2026 |
| Thyme Care | contesting | Listed as top Color alternative in oncology navigation, competing for same employer contracts |
| AccessHope | contesting | Well-funded peer navigator without ASCO Certification as of mid-2026 |
| Optum/UnitedHealth | gaining on | Integrated payer holds existing licensure and distribution, could insource oncology navigation in 2026 |
| Guardant Health | contesting | Shield test FDA-approved for colorectal screening since mid-2024, adjacent screening competitor |
- Is Color Health profitable in 2026?
- Color Health does not publish audited revenue or profit figures. Its last confirmed valuation was $4.6B from a $100M Series E in November 2021, and no new priced funding round has been reported since, as of July 2026, leaving profitability unverified.
- Could AI replace Color Health's cancer care service?
- Not easily. Color Medical is a licensed, 50-state oncologist-led group with prescribing authority and ASCO Certified status earned May 6, 2026. AI tools like its OpenAI copilot (Jan 2026) and Google Gemini-based Color Assistant (April 2026) support clinicians rather than replace the licensed medical group.
- Who owns Color Health?
- Color Health is privately held and venture-backed, founded in 2015 by Elad Gil, Nish Bhat, Taylor Sittler, with Othman Laraki as CEO. Investors include Kindred Ventures, T. Rowe Price-advised funds, General Catalyst, Viking Global, and Emerson Collective as of its November 2021 Series E.
- Who is Color Health's biggest competitor?
- Color competes with well-funded oncology navigators like Thyme Care and AccessHope in employer benefits, plus diagnostics players GRAIL and Guardant Health in cancer screening. Integrated payers Optum and CVS/Aetna pose insourcing risk given their existing licensure and distribution as of 2026.
- Has Color Health had layoffs?
- Yes. Color cut about 300 employees in March 2023 as it wound down COVID-19 testing operations. Headcount fell from a pandemic peak of 1,000+ to roughly 591 by Q4 2025, though it grew slightly (+1.1% YoY) into 2026 per workforce trackers.
- What is Color Health's Virtual Cancer Clinic?
- It's Color's core product: an oncologist-led telehealth platform covering risk assessment through survivorship, sold to employers and health plans. It became the first virtual cancer clinic to earn ASCO Certified status on May 6, 2026, and the company says it will reach over 1 million people via benefits in 2026 (vendor-claimed).
- 2026-06-09Priority Health partnership announced, virtual cancer clinic access effective January 1, 2027
- 2026-05-06Color Health earns ASCO Certified status, first virtual cancer clinic to do so
- 2026-04-22Google Cloud Gemini Enterprise Agent Platform launches, powering Color Assistant
- 2026-01-23Color launches OpenAI GPT-4o powered copilot for cancer screening guidance
- 2026-01-07Evry Health partnership announced to bolster employer health plans
- 2023-03-02Color lays off about 300 employees amid COVID-19 testing wind-down
- 2021-11Series E closes at $100M, valuation reaches roughly $4.6B
- 2021-01Series D closes at $167M led by General Catalyst, $1.5B valuation
- 2015Color Health founded by Elad Gil, Nish Bhat, Taylor Sittler, and Othman Laraki
- Color Health
- Health tech firm Color's valuation hits over $4bn after latest funding
- Color announces $167 million in Series D financing (2026-06-23)
- Color Health
- How to Buy, Valuation, Stock Price, IPO (2026-07-19)
- Color, Funding, Acquisitions & Key Rivals (2026-04-15)
- Color Health Becomes First Virtual Cancer Clinic to Earn ASCO Certified Status (2026-05-06)
- Color Health Partners with Priority Health (2026-06-09)
- Guaranteeing value in cancer care in 2026 (2026-02-24)
- Color Health Number of Employees 2026 (2026-06-29)
- Color Health lays off 300 employees amid shift away from COVID-19 testing (2023-03-02)
- Bringing cancer expertise to a doctor near you: Color's copilot and partnership with OpenAI (2026-01-23)